Starr Christopher M Insider Trades & Stock Holdings

Director · Monopar Therapeutics Inc. · Latest filing Oct 1, 2026

Starr Christopher M, Director at Monopar Therapeutics Inc. has 1 Form 4 trade on file since Oct 1, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($659.39K), net -$659.39K. Latest filing: disposed of 8.40K shares of $MNPR on Oct 1, 2026 at $78.50.

Trades on file

1

Open-market bought

$0

Open-market sold

$659.39K

Net open-market

-$659.39K

Latest filing

Oct 1, 2026

All insider trades by Starr Christopher M

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 1, 2026	$MNPR	Sell (Open-market sale) 10b5-1	8.40K	$78.50	$659.39K			+7.7%			Director		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Starr Christopher M traded

• $MNPR

Frequently asked questions

Has Starr Christopher M been buying or selling stock?

Starr Christopher M has 0 open-market purchases and 1 open-market sale on file, net -$659.39K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Starr Christopher M's latest insider trade?

disposed of 8.40K shares of $MNPR on Oct 1, 2026 at $78.50.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.